三个皮匠报告—— 严选型全行业研究报告分享下载平台，您的专属行业智库！
欢迎来到三个皮匠报告！
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置：
首页
>
行业数据
>
图表19特瑞普利单抗组与安慰剂组对比
图表19特瑞普利单抗组与安慰剂组对比
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式：PNG
图片大小：107KB
图片尺寸：2333*606
同报告图片
/
4
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
所属报告：
君实生物-中国新冠治疗的先行者全球肿瘤免疫的新力量-220422（49页）.pdf
打包全文图表
相关数据
Ph3ORIGIN3研究中Atacicept及安慰剂组受试者第36周uPCR及Gd-IgA1数据
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
收藏
行业数据
2026-03-13
原图定位
查看详情
RC18针对SDESSDAI剔除安慰剂评分下降情况对比其他药物
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
收藏
行业数据
2026-03-13
原图定位
查看详情
地达西尼安全性和安慰剂相当
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
收藏
行业数据
2025-11-24
原图定位
查看详情
部分口服GLP-1类药物的减重效果对比（安慰剂矫正）
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
收藏
行业数据
2025-11-19
原图定位
查看详情
GLP-1RA±amylin类疗法减重效果对比（安慰剂矫正）
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
收藏
行业数据
2025-11-19
原图定位
查看详情
部分GIP-1/GIPR/GCGR靶点药物的减重效果对比（安慰剂矫正）
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
收藏
行业数据
2025-11-19
原图定位
查看详情
特瑞普利单抗获国际权威指南认证助推海外放量
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
收藏
行业数据
2025-10-24
原图定位
查看详情
图表44校正安慰剂影响后载脂蛋白B变化情况
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
收藏
行业数据
2025-09-28
原图定位
查看详情
Lp(a)抑制剂的疗效：校正安慰剂效应后的Lp(a)变化百分比
fCDoja/niakgICAgICAgICAgIHwg5YmC6YeP5Y+K57uZ6I2v6aKR546HICAgICAgIHwgTHAoYSnlj5jljJbnmb7liIbmr5TvvIgl77yJIHwKfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IE9scGFzaXJhbiAgICAgIHwgMjI1bWcgUTEyVyAgICAgICAgICAgfCAtMTAxICAgICAgICAgICAgICAgICB8CnwgTXV2YWxhcGxpbiAgICAgfCAyNDBtZyBRRCAgICAgICAgICAgICB8IC04NiAgICAgICAgICAgICAgICAgIHwKfCBaZXJsYXNpcmFuICAgICB8IDMwMG1nIFExNlcgICAgICAgICAgIHwgLTgzICAgICAgICAgICAgICAgICAgfAp8IFBlbGFjYXJzZW4gICAgIHwgMjBtZyBRVyAgICAgICAgICAgICAgfCAtNzQgICAgICAgICAgICAgICAgICB8CnwgT2JpY2V0cmFwaWIgICAgfCAxMG1nIFFEICAgICAgICAgICAgICB8IC01NCAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWMu+iNr+mtlOaWue+8jOWQhOWFrOWPuOWFrOWRiu+8jOWNjuazsOeglOeptg==
收藏
行业数据
2025-09-28
原图定位
查看详情
图表43校正安慰剂影响后Lp(a)变化情况
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
收藏
行业数据
2025-09-28
原图定位
查看详情
Lp(a)抑制剂的疗效：校正安慰剂效应后的LDL变化百分比
fCDoja/nianlkI3np7AgICAgICAgfCDliYLph4/lj4rnu5noja/popHnjocgICB8IExETOWPmOWMlueZvuWIhuavlO+8iCXvvIkgfAp8LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgT2xwYXNpcmFuICAgICAgfCAyMjVtZyBRMTJXICAgICAgIHwgLTIzICAgICAgICAgICAgICAgIHwKfCBNdXZhbGFwbGluICAgICB8IDI0MG1nIFFEICAgICAgICAgfCAtMjIgICAgICAgICAgICAgICAgfAp8IFplcmxhc2lyYW4gICAgIHwgMzAwbWcgUTE2VyAgICAgICB8IC0zMCAgICAgICAgICAgICAgICB8CnwgUGVsYWNhcnNlbiAgICAgfCAyMG1nIFFXICAgICAgICAgIHwgLTE5ICAgICAgICAgICAgICAgIHwKfCBPYmljZXRyYXBpYiAgICB8IDEwbWcgUUQgICAgICAgICAgfCAtMjkgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5ZCE5YWs5Y+45YWs5ZGK77yM5Y2O5rOw56CU56m2
收藏
行业数据
2025-09-28
原图定位
查看详情
nemolizumab2期临床数据显示，12周瘙痒改善情况优异，且1周时较安慰剂改善超20%
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
收藏
行业数据
2025-09-17
原图定位
查看详情
nemolizumab2期临床数据显示，12周瘙痒改善情况优异，且1周时较安慰剂改善超20%
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
收藏
行业数据
2025-09-17
原图定位
查看详情
图表28校正安慰剂影响后Lp(a)变化情况（完整脂蛋
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
收藏
行业数据
2025-08-15
原图定位
查看详情
图表29校正安慰剂影响后Lp(a)变化情况变化情况
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
收藏
行业数据
2025-08-15
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模（亿美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模（亿美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模（百万美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
综上所述，与单纯化疗相比，特瑞普利单抗联合 GP 化疗一线治疗 RM NPC 患者可提供更长的 PFS 和 OS，以及更高的 ORR、更长的持续应答时间，安全性可管理。特瑞普利单抗联合 GP 化疗一线治疗 RM NPC 患者代表了一种新的治疗标准。
行业数据
原图定位
当前图表所属：
君实生物-中国新冠治疗的先行者全球肿瘤免疫的新力量-220422（49页）.pdf
图表7PD-1作用机理
图表56君实生物销售预测
图表54已完成的I期以及II期临床数据
JS019在澳大利亚和中国患者中均表现了显著的抗肿瘤活性和良好的安全耐受性
下载图片或Excel，需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利，扫码领取！
关注公众号『三个皮匠报告』，免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码？
验证即登录，未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》
研搜
0731-84720580
商务合作：really158d
下载Excel
下载图片
原图定位
打包全文图表
收藏
2026-03-13
原图定位
微信扫码登录
手机快捷登录
账号登录
